Trophic effects of adipose derived stem cells on Langerhans islets viability - Review

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
TRANSPLANTATION REVIEWS, v.29, n.3, p.121-126, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Langerhans islets transplantation has been proposed to provide an endogenous source of insulin in Type I diabetes. However, the hypoxic stress and the receptor's immune reaction suffered by the implants cause them to fail in sustaining the insulin production along the time. Experimental studies have shown that adipose derived stem cells (ADSCs) can secrete cytokines that activate free radical scavengers, antioxidants and chaperone heat/shock proteins leading to reduction of apoptosis in damaged tissues. Therefore, using the PubMed database, we reviewed the experimental studies that investigated the trophic effects of ADSCs on Langerhans islets viability, in vitro and in vivo, from 2009 to 2014. We excluded articles that investigated the effects of other types of mesenchymal stem cells on beta-cell survival as well articles that worked in the differentiation of ADSCs into insulin producing cells. The analysis of the experiments revealed that exposure of islets to ADSCs in vitro, even for a short period of time, can enhance islet cell viability and function. In vivo studies also corroborated the trophic effects of ADSCs leading to the improvement of islet function and reduction of the number of the islets required for controlling the receptor's glucose levels. This review can contribute to guide future experiments loolcing for a long term diabetes treatment employing ADSC trophic effects for the enhancement of transplanted Langerhans islet viability and functioning.
Palavras-chave
Referências
  1. Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
  2. Anazawa T, 2014, TRANSPL P, V46, P1980, DOI 10.1016/j.transproceed.2014.06.006
  3. Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053
  4. Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
  5. Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433
  6. Bennet W, 2000, UPSALA J MED SCI, V105, P125
  7. Bhaiji T, 2012, J BIOMED MATER RES A, V100A, P1628, DOI 10.1002/jbm.a.34111
  8. Bhang SH, 2013, BIOMATERIALS, V34, P7247, DOI 10.1016/j.biomaterials.2013.06.018
  9. Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933
  10. Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080
  11. Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489
  12. CASTELLOT JJ, 1982, P NATL ACAD SCI-BIOL, V79, P5597, DOI 10.1073/pnas.79.18.5597
  13. Cavallari G, 2012, CELL TRANSPLANT, V21, P2771, DOI 10.3727/096368912X637046
  14. Chao KC, 2008, CELL TRANSPLANT, V17, P657, DOI 10.3727/096368908786092801
  15. Citro A, 2012, J CLIN INVEST, V122, P3647, DOI 10.1172/JCI63089
  16. Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97
  17. Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
  18. Dave SD, 2014, CYTOTECHNOLOGY, V66, P299, DOI 10.1007/s10616-013-9573-3
  19. DAVE SD, 2013, BMJ CASE REP, V2013, P1
  20. De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
  21. De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
  22. Dietrich I, 2012, ACTA CIR BRAS, V27, P283, DOI 10.1590/S0102-86502012000400001
  23. Eliaschewitz FG, 2009, ARQ BRAS ENDOCRINOL, V53, P15, DOI 10.1590/S0004-27302009000100004
  24. Ezquer ME, 2012, BIOL RES, V45, P289, DOI 10.4067/S0716-97602012000300010
  25. Fraser JK, 2002, CYTOTHERAPY, V4, P509, DOI 10.1080/146532402761624647
  26. Fumimoto Y, 2009, TISSUE ENG PART C-ME, V15, P437, DOI 10.1089/ten.tec.2008.0555
  27. Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
  28. Golocheikine A, 2010, TRANSPLANTATION, V90, P725, DOI 10.1097/TP.0b013e3181ef8a63
  29. Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
  30. Iuamoto LR, 2014, WORLD J GASTROENTERO, V20, P13512, DOI 10.3748/wjg.v20.i37.13512
  31. Jun Y, 2014, BIOMATERIALS, V35, P4815, DOI 10.1016/j.biomaterials.2014.02.045
  32. Kim HI, 2010, J KOREAN MED SCI, V25, P203, DOI 10.3346/jkms.2010.25.2.203
  33. Knight E, 2014, J ANAT
  34. Lai DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098749
  35. La Manna G, 2011, CELL TRANSPLANT, V20, P1193, DOI 10.3727/096368910X543394
  36. Li DJ, 2014, CYTOTECHNOLOGY, V66, P699, DOI 10.1007/s10616-013-9569-z
  37. Li YY, 2012, BIO-MED MATER ENG, V22, P97, DOI 10.3233/BME-2012-0694
  38. LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
  39. Martins La Salete, 2014, World J Transplant, V4, P183, DOI 10.5500/wjt.v4.i3.183
  40. Ngamjariyawat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061828
  41. Niclauss N, 2014, TRANSPLANTATION, V98, P593, DOI 10.1097/TP.0000000000000288
  42. Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4
  43. Ohmura Y, 2010, TRANSPLANTATION, V90, P1366, DOI 10.1097/TP.0b013e3181ffba31
  44. O'Loughlin A, 2013, DIABETES, V62, P2588, DOI 10.2337/db12-1822
  45. Park KS, 2009, TRANSPL P, V41, P3813, DOI 10.1016/j.transproceed.2009.06.193
  46. Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103
  47. Qi M, 2014, ACTA DIABETOL, V51, P833, DOI 10.1007/s00592-014-0627-6
  48. Rackham CL, 2013, CYTOTHERAPY, V15, P449, DOI 10.1016/j.jcyt.2012.11.008
  49. Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
  50. Ryu KH, 2014, EXP CELL RES, V326, P143, DOI 10.1016/j.yexcr.2014.06.007
  51. Sakata N, 2011, WORLD J GASTROENTERO, V17, P5150, DOI 10.3748/wjg.v17.i47.5150
  52. Scuteri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084309
  53. Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
  54. Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
  55. Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
  56. Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003
  57. Souza Yngrid Ellyn Dias Maciel de, 2011, Arq Gastroenterol, V48, P146
  58. SUTHERLAND DER, 1981, ANN INTERN MED, V95, P537
  59. Tille JC, 2002, EXP CELL RES, V280, P179, DOI 10.1006/excr.2002.5635
  60. Yan K, 2014, BRAIN RES, V1590, P1, DOI 10.1016/j.brainres.2014.05.041
  61. Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010
  62. Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200
  63. Veriter S, 2011, BIOMATERIALS, V32, P5945, DOI 10.1016/j.biomaterials.2011.02.061
  64. Wang S, 2013, BIOL BLOOD MARROW TR, V19, P538, DOI 10.1016/j.bbmt.2013.01.001
  65. Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052
  66. Xu DM, 2012, DIABETOLOGIA, V55, P1091, DOI 10.1007/s00125-011-2433-9
  67. Xu YX, 2008, MED HYPOTHESES, V71, P390, DOI 10.1016/j.mehy.2008.03.046
  68. Yamada S, 2014, J SURG RES, V187, P667, DOI 10.1016/j.jss.2013.10.031
  69. Zhang L, 2013, STEM CELLS DEV, V22, P3074, DOI 10.1089/scd.2013.0142
  70. Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963
  71. Zhou SY, 2012, J PHYSIOL BIOCHEM, V68, P603, DOI 10.1007/s13105-012-0180-0
  72. Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105